2 -8 (70) 2024 - Zhumaev M.F. - CLINICAL FEATURES, DIAGNOSTIC CHALLENGES, AND THERAPEUTIC PROBLEMS IN THE TREATMENT OF RESISTANT PULMONARY TUBERCULOSIS IN THE MODERN WORLD

CLINICAL FEATURES, DIAGNOSTIC CHALLENGES, AND THERAPEUTIC PROBLEMS IN THE TREATMENT OF RESISTANT PULMONARY TUBERCULOSIS IN THE MODERN WORLD

Zhumaev M.F. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The work is based on examination data of 244 patients from the southern regions of the Republic of Uzbekistan who received treatment in the centers of phthisiology and pulmonology in the period from 2016 to 2020. The age of the patients varied from 18 to 86 years, the mean age was 52.1±2.9 years. Sick rural population was observed - in 185 (75.8%), urban population - in 56 (23.0%) and homeless people - in 3 (1.2%) cases. The analysis noted that the disease was 3.3 times more common in rural populations. Incorrect interpretation of the results of diagnostic methods of research occurred in non-phthisiatric hospitals - in 63.5% of cases, and in polyclinics - in 29.5%, and in phthisiatric hospitals this figure was - in 4.5% of cases. The analysis of the results obtained indicates that in general clinical institutions, patients are examined superficially, the full scope of the examination of patients is not performed and inadequate treatment is carried out, which leads to the progression of the tuberculosis process and the deterioration of the general condition of patients in this category.

Key words: drug-resistant pulmonary tuberculosis, diagnosis, treatment.

First page

6

Last page

11

For citation:Zhumaev M.F. - CLINICAL FEATURES, DIAGNOSTIC CHALLENGES, AND THERAPEUTIC PROBLEMS IN THE TREATMENT OF RESISTANT PULMONARY TUBERCULOSIS IN THE MODERN WORLD//New Day in Medicine 8(70)2024 6-11 https://newdayworldmedicine.com/en/new_day_medicine/8-70-2024

List of References

1. Мякишева Т.В. Социальный статус, клинико-рентгенологические проявления впервые выявленного туберкулёза легких у молодого возраста с лекарственной устойчивостью микобактерий //Сибирский медицинский журнал, 2012;27(1):160-164.
2. Пунга В.В., Русакова Л.И., Пузанов В.А. и соавт.. Распространенность туберкулеза с лекарственной устойчивостью //Туберкулез и болезни легких. 2011;10:6-15.
3. Русских А.Е., Кутузова Д.М., Ловачева О.В., Самойлова А.Г., Васильева И.А. Краткосрочные схемы лечения больных туберкулезом с множественной лекарственной устойчивостью. Современная ситуация и дальнейшие перспективы //Туберкулёз и болезни лёгких. 2020;98(12):57-66.
4. Скрягина Е.М. Диагностика и лечение туберкулеза легких //Рецепт. 2007;6:42-51.
5. Усмонов И.Х., Жумаев М. Ф., Состояние лекарственно-устойчивых форм туберкулёза легких в современных условиях. //Вестник Ташкентской медицинской академии. 2021;3:55-64.
6. Usmonov I.Kh., Muazzamov B.R., Jumaev M.F. Features of Diagnostics and Treatment of Drug-Resistant Forms of Pulmonary Tuberculosis, //International Journal of Pharmaceutical Research 2021 Jan – Mar;13(1):2484-2489.
7. Jumaev M. F., Usmonov I. Kh. Clinical Course and Modern Diagnosis of Resistant Forms of Pulmonary Tuberculosis, //American journal of social and humanitarian research 2022;2(3):250-260.
8. Pranger A. D. et al. The role of fluoroquinolones in the treatment of tuberculosis in 2019 //Drugs. Springer International Publishing. 2019;79(2):161-171.
9. WHO Consolidated guidelines on tuberculosis, Module 4: treatment ‒drug-resistant tuberculosis treatment [Electronic resource]. URL: https://www.who.int/publications/i/item/9789240007048 (accessed: 05.08.2020).

   file

   download